FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry and specifically to a heterocyclic compound of formula (IIA) or a pharmaceutically acceptable salt thereof, where E denotes -CH2-; Q is -CH2-, -CH2O- or -CH2OCN2-; Z is hydrogen or methyl; R1 denotes -SO2Ra, -CORd or -CO2Rd; or R1 denotes C1–C6-alkyl, this group may optionally contain one or three substitutes independently selected from halogen and C2–C6-alkoxycarbonyl; R12 denotes hydrogen; R15 means halogen; R16 means halogen; Ra denotes C1–C6-alkyl and Rd denotes trifluoromethyl or C1–C6-alkyl. Invention also relates to a pharmaceutical composition based on the compound of formula (IIA), use of the compound of formula (IIA) and a method of treating and/or preventing rheumatoid arthritis or Crohn's disease.
EFFECT: technical result: obtaining novel heterocyclic compounds having the properties of a TNFα activity modulator.
5 cl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684635C1 |
IMIDAZOPYRIMIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2691629C1 |
IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2696275C1 |
TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2696270C1 |
IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2678305C1 |
IMIDAZOPYRIDAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2679609C1 |
IMIDAZOTHIAZOLE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2683940C1 |
PYRAZOLOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2684641C1 |
CONDENSED BICYCLIC HETEROAROMATIC DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2685234C1 |
CONDENSED DERIVATIVES OF IMIDAZOLE AND PYRAZOLE AS MODULATORS OF ACTIVITY TNF | 2014 |
|
RU2686117C1 |
Authors
Dates
2019-08-12—Published
2014-12-08—Filed